Dichotomous effects of exposure to bivalirudin in patients undergoing percutaneous coronary intervention on protease-activated receptor-mediated platelet activation-Reference-Cited by-同舟云学术

Dichotomous effects of exposure to bivalirudin in patients undergoing percutaneous coronary intervention on protease-activated receptor-mediated platelet activation

Published:2012-09-30 Issue:2 Volume:35 Page:209-222
ISSN:0929-5305
Container-title:Journal of Thrombosis and Thrombolysis
language:en
Short-container-title:J Thromb Thrombolysis

Author:

Holinstat Michael,Colowick Nancy E.,Hudson Willie J.,Blakemore Dana,Chen Qingxia,Hamm Heidi E.,Cleator John H.

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine,Hematology

Link

http://link.springer.com/content/pdf/10.1007/s11239-012-0812-9.pdf

Reference40 articles.

1. Patterson C, Stouffer GA, Madamanchi N, Runge MS (2001) New tricks for old dogs: nonthrombotic effects of thrombin in vessel wall biology. Circ Res 88:987–997

2. Jamieson GA (1997) Pathophysiology of platelet thrombin receptors. J Thromb Haemostasis 78:242–246

3. Coughlin SR (2000) Thrombin signalling and protease-activated receptors. Nature 407:258–264

4. Coughlin SR (2005) Protease-activated receptors in hemostasis, thrombosis and vascular biology. J Thromb Haemostasis 3:1800–1814. doi: 10.1111/j.1538-7836.2005.01377.x

5. Leger AJ, Covic L, Kuliopulos A (2006) Protease-activated receptors in cardiovascular diseases. Circulation 114:1070–1077

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Enhanced potency of prasugrel on protease-activated receptors following bivalirudin treatment for PCI as compared to clopidogrel;Thrombosis Research;2019-05

2. Comparison of the antiplatelet and antithrombotic effects of bivalirudin versus unfractionated heparin: A platelet substudy of the HEAT PPCI trial;Thrombosis Research;2018-12

3. Pretreatment with ticagrelor may offset additional inhibition of platelet and coagulation activation with bivalirudin compared to heparin during primary percutaneous coronary intervention;Thrombosis Research;2018-11

4. Racial Differences in Resistance to P2Y12Receptor Antagonists in Type 2 Diabetic Subjects;Journal of Pharmacology and Experimental Therapeutics;2014-07-22